We combined quantitative the nuclear magnetic resonance (NMR) spectroscopy serum
analysis of metabolites, lipoproteins and inflammation markers with clinical parameters and
a targeted cytokine panel to characterize COVID-19 in a large (534 patient samples, 305
controls) outpatient cohort of recently tested PCR-positive patients. The COVID-19 cohort
consisted of patients who were predominantly in the initial phase of the disease and mostly …